Literature DB >> 16622137

Adiponectin and risk of congestive heart failure.

Erik Ingelsson, Ulf Risérus, Christian Berne, Jan Frystyk, Allan Flyvbjerg, Tomas Axelsson, Per Lundmark, Björn Zethelius.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16622137     DOI： 10.1001/jama.295.15.1772-c

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.

Authors:  Tobias Pischon; Frank B Hu; Cynthia J Girman; Nader Rifai; JoAnn E Manson; Kathryn M Rexrode; Eric B Rimm
Journal:  Atherosclerosis       Date:  2011-07-20       Impact factor: 5.162

2.  Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.

Authors:  Karen M O'Shea; David J Chess; Ramzi J Khairallah; Sharad Rastogi; Peter A Hecker; Hani N Sabbah; Kenneth Walsh; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-26       Impact factor: 4.733

3.  Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease.

Authors:  Ken Shinmura
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 4.  Biomarkers: optimizing treatment guidance in heart failure.

Authors:  Michael Böhm; Adriaan A Voors; Jean-Marie Ketelslegers; Stephan H Schirmer; Eva Turgonyi; Peter Bramlage; Faiez Zannad
Journal:  Clin Res Cardiol       Date:  2011-07-16       Impact factor: 5.460

Review 5.  Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism.

Authors:  Linda R Peterson
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

6.  Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy.

Authors:  Rui Guo; Yingmei Zhang; Subat Turdi; Jun Ren
Journal:  Biochim Biophys Acta       Date:  2013-03-21

7.  Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

Authors:  Rei Shibata; Yasuhiro Izumiya; Kaori Sato; Kyriakos Papanicolaou; Shinji Kihara; Wilson S Colucci; Flora Sam; Noriyuki Ouchi; Kenneth Walsh
Journal:  J Mol Cell Cardiol       Date:  2007-03-20       Impact factor: 5.000

8.  Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).

Authors:  Maria G Karas; David Benkeser; Alice M Arnold; Traci M Bartz; Luc Djousse; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; Russell P Tracy; Christos S Mantzoros; John S Gottdiener; Christopher R deFilippi; Jorge R Kizer
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

9.  Resistin, adiponectin, and risk of heart failure the Framingham offspring study.

Authors:  David S Frankel; Ramachandran S Vasan; Ralph B D'Agostino; Emelia J Benjamin; Daniel Levy; Thomas J Wang; James B Meigs
Journal:  J Am Coll Cardiol       Date:  2008-12-26       Impact factor: 24.094

10.  Association between adiponectin and heart failure risk in the physicians' health study.

Authors:  Luc Djoussé; Jemma B Wilk; Naomi Q Hanson; Robert J Glynn; Michael Y Tsai; J Michael Gaziano
Journal:  Obesity (Silver Spring)       Date:  2013-04       Impact factor: 5.002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.